Hospital of the City of Ludwigshafen, Medical Clinic B and Institute of Heart Attack Research, Ludwigshafen on the Rhine, Germany.
Institute of Cardiovascular Sciences, Birmingham University, Birmingham, UK.
Eur Heart J Qual Care Clin Outcomes. 2020 Apr 1;6(2):100-104. doi: 10.1093/ehjqcco/qcz042.
The Acute Cardiac Care Association (ACCA)-European Association of Percutaneous Coronary Intervention (EAPCI) Registry on ST-elevation myocardial infarction (STEMI) of the EurObservational programme (EORP) of the European Society of Cardiology (ESC) registry aimed to determine the current state of the use of reperfusion therapy in ESC member and ESC affiliated countries and the adherence to ESC STEMI guidelines in patients with STEMI.
Between 1 January 2015 and 31 March 2018, a total of 11 462 patients admitted with an initial diagnosis of STEMI according to the 2012 ESC STEMI guidelines were enrolled. Individual patient data were collected across 196 centres and 29 countries. Among the centres, there were 136 percutaneous coronary intervention centres and 91 with cardiac surgery on-site. The majority of centres (129/196) were part of a STEMI network. The main objective of this study was to describe the demographic, clinical, and angiographic characteristics of patients with STEMI. Other objectives include to assess management patterns and in particular the current use of reperfusion therapies and to evaluate how recommendations of most recent STEMI European guidelines regarding reperfusion therapies and adjunctive pharmacological and non-pharmacological treatments are adopted in clinical practice and how their application can impact on patients' outcomes. Patients will be followed for 1 year after admission.
The ESC ACCA-EAPCI EORP ACS STEMI registry is an international registry of care and outcomes of patients hospitalized with STEMI. It will provide insights into the contemporary patient profile, management patterns, and 1-year outcome of patients with STEMI.
欧洲心脏病学会(ESC)的 EurObservational programme(EORP)的急性心脏护理协会(ACCA)-欧洲经皮冠状动脉介入治疗协会(EAPCI)ST 段抬高型心肌梗死(STEMI)登记处旨在确定 ESC 成员国和 ESC 附属国家目前再灌注治疗的使用情况以及符合 ESC STEMI 指南的 STEMI 患者的治疗情况。
2015 年 1 月 1 日至 2018 年 3 月 31 日,根据 2012 年 ESC STEMI 指南,共纳入 11462 例初始诊断为 STEMI 的患者。在 29 个国家的 196 个中心收集了患者的个人数据。在这些中心中,有 136 个经皮冠状动脉介入治疗中心和 91 个有心脏手术的中心。大多数中心(129/196)属于 STEMI 网络的一部分。本研究的主要目的是描述 STEMI 患者的人口统计学、临床和血管造影特征。其他目标包括评估管理模式,特别是再灌注治疗的当前使用情况,并评估最近的 STEMI 欧洲指南中关于再灌注治疗和辅助药物及非药物治疗的建议在临床实践中的应用情况,以及其应用如何影响患者的预后。患者将在入院后随访 1 年。
ESC ACCA-EAPCI EORP ACS STEMI 登记处是一个国际 STEMI 患者护理和结局登记处。它将提供对当代患者特征、管理模式和 STEMI 患者 1 年结局的深入了解。